Tsuyoshi Terashima
No ORCID on file
· 1 paper in corpus
· active 2021
Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyos…